$2.90
0.85% yesterday
Nasdaq, Sep 27, 09:42 pm CET
ISIN
US02156U1016
Symbol
ATER

Aterian Inc Stock News

Neutral
Seeking Alpha
about 2 months ago
Aterian, Inc. (NASDAQ:ATER ) Q2 2024 Earnings Conference Call August 8, 2024 5:00 PM ET Company Participants Ilya Grozovsky - Vice President, Investor Relations & Corporate Development Arturo Rodriguez - Chief Executive Officer Josh Feldman - Chief Financial Officer Conference Call Participants Brian Kinstlinger - Alliance Global Partners Alex Furman - Craig Hallum Capital Group Operator Thank ...
Neutral
GlobeNewsWire
2 months ago
SUMMIT, N.J., July 29, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian”) announced today that it plans to report its second quarter 2024 financial results after the market close on Thursday, August 8, 2024, and plans to host a conference call for investors and interested parties at 5:00 p.m. ET that evening.
Positive
Seeking Alpha
3 months ago
After the close of Wednesday's regular session, e-commerce brand consolidator Aterian raised Q2 expectations for botth the top- and bottom line. Following years of revenue declines and material cash burn, the company is finally showing signs of life. At the high-end of the increased range, the company would break-even on an Adjusted EBITDA basis for the first time since Q3/2021.
Neutral
GlobeNewsWire
3 months ago
Arturo Rodriguez Appointed CEO Josh Feldman Appointed CFO Second Quarter 2024 Net Revenue Range Improved to Between $23 Million to $26 Million Second Quarter 2024 Adjusted EBITDA Range Improved to Between a Loss of ($1.0) Million to $0.0 Million NEW YORK, June 26, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced the appointment of Arturo (Arty) ...
Neutral
Business Wire
4 months ago
NEW YORK & MIAMI--(BUSINESS WIRE)--Aterian Investment Partners (“Aterian”), a private investment firm, is pleased to announce that one of its affiliates has closed its acquisition of Contract Pharmaceuticals Limited Canada (“CPL” or the “Company”), a leading North American contract development and manufacturing organization (CDMO) of non-sterile liquid and semi-solid dosage forms. Based in Miss...
Neutral
Seeking Alpha
5 months ago
Aterian, Inc. (NASDAQ:ATER ) Q1 2024 Earnings Conference Call May 7, 2024 5:00 PM ET Company Participants Ilya Grozovsky - Vice President, IR & Corporate Development Joseph Risico - Co-CEO Arturo Rodriguez - Co-CEO & CFO Conference Call Participants Brian Kinstlinger - Alliance Global Partners Marvin Fong - BTIG Operator Thank you for standing by. My name is Alex, and I will be your conference ...
Neutral
GlobeNewsWire
5 months ago
First Quarter Net Loss Improved by 80.0% Year Over Year and Adjusted EBITDA Loss Improved by 38.4% Affirms Second Half 2024 Adjusted EBITDA Profitability Target NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced results for the first quarter ended March 31, 2024.  First Quarter Highlights First quarter 2024 net revenue declined 4...
Neutral
GlobeNewsWire
5 months ago
NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian”) announced today that it plans to report its first quarter 2024 financial results after the market close on Tuesday, May 7, 2024, and plans to host a conference call for investors and interested parties at 5:00 p.m. ET that evening.

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today